{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:41:39Z","timestamp":1765608099028},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/gco.0b013e3281338874","type":"journal-article","created":{"date-parts":[[2007,5,10]],"date-time":"2007-05-10T08:04:13Z","timestamp":1178784253000},"page":"258-265","source":"Crossref","is-referenced-by-count":24,"title":["Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function"],"prefix":"10.1097","volume":"19","author":[{"given":"Andrea J","family":"DiLuigi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C","family":"Nulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/oxfordjournals.humrep.a137105","article-title":"The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in vitro fertilization and embryo transfer","volume":"5","author":"Loumaye","year":"1990","journal-title":"Hum Reprod"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0015-0282(02)04920-8","article-title":"Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy","volume":"79","author":"Kolibianakis","year":"2003","journal-title":"Fertil Steril"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1016\/S0021-9258(19)34163-8","article-title":"The amino acid sequence of a peptide with growth hormone-releasing activity isolated from porcine hypothalamus","volume":"246","author":"Schally","year":"1971","journal-title":"J Biol Chem"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The science behind 25 years of ovarian hyperstimulation for in vitro fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr Rev"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/978-1-4684-3474-3_75","article-title":"Inhibitory effects of treatment with LHRH or its agonists on ovarian receptor levels and function","volume":"112","author":"Labrie","year":"1979","journal-title":"Adv Exp Med Biol"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.fertnstert.2005.02.011","article-title":"Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?","volume":"83","author":"Fauser","year":"2005","journal-title":"Fertil Steril"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003495-199652030-00002","article-title":"In vitro fertilization. A review of drug therapy and clinical management","volume":"52","author":"Jennings","year":"1996","journal-title":"Drugs"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0015-0282(16)60851-8","article-title":"Improved pregnancy outcome with the addition of leuprolide acetate to gonadotropins for in vitro fertilization","volume":"52","author":"Chetkowski","year":"1989","journal-title":"Fertil Steril"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0015-0282(16)55430-2","article-title":"The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials","volume":"58","author":"Hughes","year":"1992","journal-title":"Fertil Steril"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1043-2760(03)00075-4","article-title":"Reproductive biology and IVF: ovarian stimulation and luteal phase consequences","volume":"14","author":"Fauser","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bpobgyn.2006.08.002","article-title":"GnRH agonists vs. antagonists","volume":"21","author":"Tarlatzis","year":"2007","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2001.tb03790.x","article-title":"Ovulation induction disrupts luteal phase function","volume":"943","author":"Tavaniotou","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0378(01)00134-6","article-title":"Impact of ovarian stimulation on corpus luteum function and embryonic implantation","volume":"55","author":"Tavaniotou","year":"2002","journal-title":"J Reprod Immunol"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2004.01.009","article-title":"Reproductive biology and IVF: ovarian stimulation and endometrial receptivity","volume":"15","author":"Devroey","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.grf.0000197520.53682.32","article-title":"The use of gonadotropin-releasing hormone antagonist in ovarian stimulation","volume":"49","author":"Olivennes","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.377491","article-title":"Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor","volume":"205","author":"Casper","year":"1979","journal-title":"Science"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1126\/science.6797068","article-title":"Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control","volume":"215","author":"Sheehan","year":"1982","journal-title":"Science"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/oxfordjournals.humrep.a137831","article-title":"Pituitary gonadotropin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol","volume":"7","author":"Smitz","year":"1992","journal-title":"Hum Reprod"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/oxfordjournals.humrep.a137671","article-title":"Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long-acting agonist of gonadotropin-releasing hormone","volume":"7","author":"Herman","year":"1992","journal-title":"Hum Reprod"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(98)00135-6","article-title":"The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix","volume":"70","author":"Albano","year":"1998","journal-title":"Fertil Steril"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1210\/jc.2002-021953","article-title":"Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment","volume":"88","author":"Beckers","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S1472-6483(10)61435-6","article-title":"Luteal hormone profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles","volume":"13","author":"Tavaniotou","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1472-6483(10)60976-5","article-title":"Luteal phase characteristics following GnRH antagonist or agonist treatment \u2013 a comparative study","volume":"12","author":"Friedler","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0015-0282(16)45852-8","article-title":"Corpus luteum function after follicle aspiration for oocyte retrieval","volume":"36","author":"Garcia","year":"1981","journal-title":"Fertil Steril"},{"key":"R25-10-20210129","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/humrep\/16.11.2258","article-title":"Comparison of luteal phase profile in gonadotropin stimulated cycles with or without a gonadotropin-releasing hormone antagonist","volume":"16","author":"Ragni","year":"2001","journal-title":"Hum Reprod"},{"key":"R26-10-20210129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.fertnstert.2005.07.1330","article-title":"Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination","volume":"85","author":"Duffy","year":"2006","journal-title":"Fertil Steril"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0015-0282(16)47536-9","article-title":"Advanced endometrial maturation after ovulation induction with human menopausal gonadotropin\/human chorionic gonadotropin for in vitro fertilization","volume":"41","author":"Garcia","year":"1984","journal-title":"Fertil Steril"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oxfordjournals.humrep.a136667","article-title":"The luteal phase after in-vitro fertilization and related procedures","volume":"3","author":"Van Steirteghem","year":"1988","journal-title":"Hum Reprod"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0015-0282(16)60496-X","article-title":"Assessing the early luteal phase in in vitro fertilization cycles: relationships between plasma steroids, endometrial receptors, and endometrial histology","volume":"51","author":"Forman","year":"1989","journal-title":"Fertil Steril"},{"key":"R30-10-20210129","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0015-0282(16)56648-5","article-title":"Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony","volume":"61","author":"Benadiva","year":"1994","journal-title":"Fertil Steril"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0002-9378(97)70344-2","article-title":"The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation","volume":"176","author":"Kolb","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0015-0282(02)03323-X","article-title":"Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up","volume":"78","author":"Kolibianakis","year":"2002","journal-title":"Fertil Steril"},{"key":"R33-10-20210129","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/humupd\/dmg045","article-title":"The endometrium in stimulated cycles for IVF","volume":"9","author":"Bourgain","year":"2003","journal-title":"Hum Reprod Update"},{"key":"R34-10-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0015-0282(98)00390-2","article-title":"Effect of exogenous gonadotropins on endometrial maturation in oocyte donors","volume":"71","author":"Meyer","year":"1999","journal-title":"Fertil Steril"},{"key":"R35-10-20210129","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/humupd\/dml033","article-title":"The human endometrium as a fertility-determining factor","volume":"12","author":"Strowitzki","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R36-10-20210129","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0024-3205(98)00045-9","article-title":"Possible direct effect of gonadotropin releasing hormone on human endometrium and decidua","volume":"62","author":"Takeuchi","year":"1998","journal-title":"Life Sci"},{"key":"R37-10-20210129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.fertnstert.2005.08.023","article-title":"Expression of L-selectin ligands in human endometrium during the implantation window after controlled ovarian hyperstimulation for oocyte donation","volume":"85","author":"Lai","year":"2006","journal-title":"Fertil Steril"},{"key":"R38-10-20210129","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/humrep\/deh793","article-title":"Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Hum Reprod"},{"key":"R39-10-20210129","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/humrep\/dei243","article-title":"Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles","volume":"20","author":"Simon","year":"2005","journal-title":"Hum Reprod"},{"key":"R40-10-20210129","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0015-0282(16)56647-3","article-title":"Endometrial structure after superovulation: a prospective controlled study","volume":"61","author":"Macrow","year":"2004","journal-title":"Fertil Steril"},{"key":"R41-10-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(16)30062-0","article-title":"Dating the endometrial biopsy","volume":"1","author":"Noyes","year":"1950","journal-title":"Fertil Steril"},{"key":"R42-10-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.grf.0000197521.61306.51","article-title":"The uterus and in vitro fertilization","volume":"49","author":"De Ziegler","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"R43-10-20210129","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.fertnstert.2003.11.030","article-title":"A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women","volume":"81","author":"Murray","year":"2004","journal-title":"Fertil Steril"},{"key":"R44-10-20210129","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.fertnstert.2004.03.069","article-title":"Histological dating of timed endometrial biopsy tissue is not related to fertility status","volume":"82","author":"Coutifaris","year":"2004","journal-title":"Fertil Steril"},{"key":"R45-10-20210129","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/humupd\/dml004","article-title":"Endometrial receptivity markers, the journey to successful implantation","volume":"12","author":"Achache","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R46-10-20210129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.1079546","article-title":"Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface","volume":"299","author":"Genbacev","year":"2003","journal-title":"Science"},{"key":"R47-10-20210129","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2006-0520","article-title":"Effect of luteal-phase support on endometrial L-selectin ligand expression after recombinant follicle-stimulating hormone and ganirelix acetate for in vitro fertilization","volume":"91","author":"Vlahos","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-10-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"R49-10-20210129","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"R50-10-20210129","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0015-0282(16)55083-3","article-title":"Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization","volume":"57","author":"Segal","year":"1992","journal-title":"Fertil Steril"},{"key":"R51-10-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0015-0282(16)58404-0","article-title":"Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH-antagonist","volume":"66","author":"Olivennes","year":"1996","journal-title":"Fertil Steril"},{"key":"R52-10-20210129","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/humrep\/13.4.811","article-title":"Induction of the endogenous gonadotropin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose","volume":"13","author":"Buckett","year":"1998","journal-title":"Hum Reprod"},{"key":"R53-10-20210129","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1093\/humrep\/13.12.3315","article-title":"Human chorionic gonadotropin luteal support overcomes luteal phase inadequacy after gonadotropin-releasing hormone agonist-induced ovulation in gonadotropin-stimulated cycles","volume":"13","author":"Pe\u00f1arrubia","year":"2006","journal-title":"Hum Reprod"},{"key":"R54-10-20210129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/oxfordjournals.humrep.a138520","article-title":"Induction of preovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome","volume":"9","author":"Shalev","year":"1994","journal-title":"Hum Reprod"},{"key":"R55-10-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"R56-10-20210129","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","article-title":"Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian hyperstimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report","volume":"15","author":"Itskovitz-Eldor","year":"2000","journal-title":"Hum Reprod"},{"key":"R58-10-20210129","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"R59-10-20210129","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"key":"R60-10-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1472-6483(10)60615-3","article-title":"Substituting HCG with GnRH agonist to trigger final follicular maturation: a retrospective comparison of three different ovarian stimulation protocols","volume":"13","author":"Orvieto","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"R61-10-20210129","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization","volume":"87","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R62-10-20210129","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1472-6483(10)60653-0","article-title":"GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS","volume":"13","author":"Engmann","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"R63-10-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmi045","article-title":"GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systemic review and meta-analysis","volume":"12","author":"Griesinger","year":"2006","journal-title":"Hum Reprod Update"},{"key":"R64-10-20210129","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.fertnstert.2006.05.049","article-title":"Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates","volume":"86","author":"Acevedo","year":"2006","journal-title":"Fertil Steril"},{"key":"R65-10-20210129","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/humrep\/deh235","article-title":"Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation","volume":"19","author":"Tesarik","year":"2004","journal-title":"Hum Reprod"},{"key":"R66-10-20210129","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/humrep\/deh830","article-title":"GnRH agonist as novel luteal phase support: results of a randomized, parallel group, feasibility study using intranasal buserelin","volume":"20","author":"Pirard","year":"2005","journal-title":"Hum Reprod"},{"key":"R67-10-20210129","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/humrep\/del072","article-title":"GnRH agonist as luteal phase support in assisted reproductive technique cycles: results of a pilot study","volume":"21","author":"Pirard","year":"2006","journal-title":"Hum Reprod"},{"key":"R68-10-20210129","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1093\/humrep\/del173","article-title":"Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH-agonist- and antagonist-treated ovarian stimulation cycles","volume":"21","author":"Tesarik","year":"2006","journal-title":"Hum Reprod"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GCO.0b013e3281338874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:46:37Z","timestamp":1620953197000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001703-200706000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e3281338874","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}